Figure 1.
Biological markers predictive of clinical evolution in early multiple sclerosis. MS, multiple sclerosis; CSF, cerebrospinal fluid; RIS, radiologically isolated syndrome; CIS, clinically isolated syndrome; PMS, progressive MS; 25(OH)D, 25-hydroxy vitamin D; EBNA1-IgG, Epstein–Barr Virus-encoded nuclear antigen 1 specific immunoglobulin G; OCBs, oligoclonal bands; CHI3L1, chitinase 3-like protein 1; CHI3L2, chitinase 3-like protein 2; GFAP, glial fibrillary acidic protein; NFL, neurofilament-light chain; kFLC, kappa Free Light Chains; miRNA, microRNA.
